Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, August 25, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Paul Chaplin
2.
Reason for the notification
a)
Position/status
President and Chief Executive Officer of Bavarian Nordic A/S
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Bavarian Nordic A/S
b)
LEI
2138006JCDVYIN6INP51
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument Identification code
Shares DK0015998017
b)
Nature of the transaction
Sale
c)
Price(s) and volume(s)
Price(s)
Volume(s)
DKK 212.4214
90,000
d)
Aggregated information Aggregated volumePrice
90,000 DKK 19,117,925.90
e)
Date of the transaction
2026-08-24
f)
Place of the transaction
Nasdaq Copenhagen A/S, XCSE
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Maria Tzatzaris
2.
Reason for the notification
a)
Position/status
Closely associated with Paul Chaplin, President and Chief Executive Officer of Bavarian Nordic A/S
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Bavarian Nordic A/S
b)
LEI
2138006JCDVYIN6INP51
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument Identification code
Shares DK0015998017
b)
Nature of the transaction
Sale
c)
Price(s) and volume(s)
Price(s)
Volume(s)
DKK 207.91
14,840
d)
Aggregated information Aggregated volumePrice
14,840 DKK 3,085,384.40
e)
Date of the transaction
2026-08-21
f)
Place of the transaction
Nasdaq Copenhagen A/S, XCSE
About Bavarian Nordic
Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit www.bavarian-nordic.com
Contact investors:
Anders Hjort, Head of Investor Relations, [email protected], Tel: +45 44 74 99 58 Graham Morrell, Gilmartin Group, [email protected], Tel: +1 781 686 9600
Contact media:
Isabel Hagbrink, Head of Media Relations, [email protected], Tel: +45 71 79 67 33
Company Announcement no. 37 / 2026
Attachment
- Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Summary
COPENHAGEN, Denmark, August 25, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.